Last reviewed: June 16, 2026

Last updated: June 16, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, a GLP-1 receptor agonist originally developed for type 2 diabetes, has emerged as a powerful tool for weight management in non-diabetic adults. Clinical trials show that participants using semaglutide lose significantly more weight than those on placebo—but the exact amount depends on your unique physiology, adherence, and individual response patterns.

Average Weight Loss Results with Semaglutide Injections

The STEP trials, which examined semaglutide for chronic weight management, documented average weight loss of 10-15% of baseline body weight over 68 weeks at the 2.4 mg maintenance dose. This translates to roughly 1-2 pounds per week for most participants, though weight loss typically plateaus after 6 months as the body reaches a new metabolic equilibrium. The medication works by slowing gastric emptying, increasing feelings of fullness, and reducing hunger signals in the brain—creating a sustainable caloric deficit without extreme dietary restriction.

Individual outcomes vary considerably based on starting weight, baseline metabolism, and treatment adherence. Someone starting at 250 pounds might lose 30-35 pounds over six months, while another person at 180 pounds could lose 18-25 pounds in the same timeframe. PlexusDx's semaglutide injection, compounded at licensed 503A pharmacies and starting at $149 per month, delivers the same active pharmaceutical ingredient as branded versions but at a significantly lower cost, making sustained treatment more accessible.

Timeline: When You'll Notice Weight Loss Changes

Weight loss on semaglutide typically begins within 2-4 weeks of starting therapy, as appetite suppression kicks in and eating patterns shift downward. Most users report losing 2-5 pounds in the first month, though this initial drop often reflects both fat loss and reduced water retention from decreased caloric intake. By week 8-12, the rate of loss accelerates as metabolic adaptation occurs and the 0.5-1.0 mg dose range becomes established.

Significant body composition changes—where you visibly see fat loss in the face, midsection, and thighs—typically appear between weeks 12-16. The most dramatic weight loss phase occurs between months 2-5, when most patients reach or approach their therapeutic dose. By month 6-7, weight loss usually slows to a plateau as your body stabilizes at a new weight set point, though many users continue losing 5-10 additional pounds over months 8-12 if they maintain consistent dosing and lifestyle habits.

Factors That Affect Your Individual Weight Loss Amount

Genetics play a substantial role in determining how much weight you'll lose and how quickly. Variants in the FTO gene (rs9939609), GLP1R gene (rs6923761), GIPR gene (rs1800437), and MC4R gene (rs17782313) influence appetite regulation, energy expenditure, and metabolic response to GLP-1 therapy. PlexusDx's Precision Peptide Genetic Test, a $99 add-on after your first month of treatment, maps 14 metabolic pathways and 49 peptides to reveal your genetic predispositions—allowing your provider to optimize your semaglutide protocol or potentially recommend alternative compounds like tirzepatide if your genetic profile suggests a stronger response.

Behavioral and lifestyle factors are equally critical. Users who maintain consistent physical activity (150+ minutes per week), prioritize protein intake (25-30g per meal), and avoid high-calorie beverages typically lose 20-30% more weight than sedentary users consuming excess sugar. Sleep quality, stress levels, and medication adherence also significantly impact outcomes. Someone taking semaglutide consistently every week will lose substantially more weight than someone with inconsistent dosing patterns, which is why PlexusDx emphasizes patient education and accessible pricing to remove barriers to sustained treatment.

Comparing Semaglutide to Other GLP-1 Weight Loss Medications

Semaglutide and tirzepatide (a GLP-1/GIP dual receptor agonist) both produce significant weight loss, but tirzepatide generally delivers 3-5% greater total body weight reduction in head-to-head trials. A 2023 study found tirzepatide users lost approximately 21% of baseline body weight compared to 16% for semaglutide at comparable dose levels. However, semaglutide has a longer clinical track record, potentially lower side-effect severity for some users, and may be the optimal choice for those with certain genetic profiles or medical histories. PlexusDx offers both compounded semaglutide injection ($149-$189/month across commitment tiers) and compounded tirzepatide injection ($249-$289/month), allowing your provider to select the compound that best matches your genetic predispositions and clinical response.

PlexusDx also offers GLP-Squared Injection, a dual-compound protocol combining semaglutide and tirzepatide for patients with specific genetic markers suggesting synergistic benefit. Additionally, oral formulations (semaglutide at $249/month, tirzepatide at $279/month) provide an alternative for injection-averse patients, though oral medications typically show 20-30% lower bioavailability and thus slightly reduced weight loss compared to injections. Your dose may need to go up as you progress through treatment, but your price won't—PlexusDx charges a flat monthly rate regardless of dose escalation.

Managing Expectations and Maintaining Weight Loss Long-Term

Weight loss on semaglutide is not linear, and plateaus of 2-4 weeks without scale movement are completely normal as your metabolism adjusts. Some users experience a dramatic initial drop (15-20 pounds in 4-6 weeks) followed by a slower phase, while others see steady 3-4 pound weekly losses. Patience and consistency matter more than the speed of loss; users who view semaglutide as a long-term tool rather than a short-term fix achieve better sustained outcomes. Discontinuing semaglutide often leads to weight regain within 6-12 months unless significant lifestyle changes have become permanent habits.

Long-term weight loss maintenance on semaglutide requires ongoing medication use, typically 2-5 years minimum based on current clinical evidence. The good news: PlexusDx's accessibility model removes cost barriers that prevent many patients from remaining on therapy long-term. Starting at $149 per month for semaglutide injection with no membership fee, insurance requirement, or commitment contract, PlexusDx makes sustained weight loss treatment affordable for individuals across all socioeconomic backgrounds. HSA and FSA accounts are eligible, further reducing out-of-pocket costs. Pairing medication with behavioral support, regular physical activity, and potentially the Precision Peptide Genetic Test for personalized optimization creates the strongest foundation for lasting results.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How much weight will I lose in the first month on semaglutide?

Most users lose 2-5 pounds in the first month as appetite suppression begins and caloric intake naturally decreases. This initial loss includes both fat and water weight. Expect more significant monthly losses (5-8 pounds) by month 2-3 as you reach therapeutic dosing with PlexusDx's semaglutide injection.

Is 10-15% body weight loss realistic for everyone?

The 10-15% average from clinical trials applies to most users, but genetic variants and lifestyle factors create a wide range of outcomes—from 5-8% loss in some individuals to 20-25% in others with optimal genetics and adherence. PlexusDx's Precision Peptide Genetic Test identifies your individual genetic predisposition to GLP-1 response, helping set realistic personalized expectations.

Why is PlexusDx semaglutide ($149/month) more affordable than brand versions?

PlexusDx sources semaglutide from licensed 503A compounding pharmacies, which can manufacture the same active pharmaceutical ingredient at lower costs than brand manufacturers. Removing insurance intermediaries and membership fees further reduces your out-of-pocket expense, making sustained long-term treatment accessible.

What if I stop taking semaglutide—will I regain the weight?

Studies show most users regain 50-70% of lost weight within 1-2 years after discontinuing semaglutide, highlighting the importance of long-term therapy. Permanent lifestyle changes (diet, exercise) begun during treatment increase your chances of maintaining some weight loss after stopping.

Can genetic testing help me lose more weight on semaglutide?

Yes. PlexusDx's Precision Peptide Genetic Test ($99 add-on) reveals variants in FTO, GLP1R, GIPR, and MC4R genes that influence your response. If your genetic profile suggests weaker semaglutide response, your provider may recommend tirzepatide or GLP-Squared Injection for potentially better outcomes based on your unique biology.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves